We are live on ! Find out more
PASG icon

Passage Bio
PASG

101 hedge funds and large institutions have $419M invested in Passage Bio in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

0.24% less ownership

Funds ownership: 4.13% → 3.89% (-0.24%)

1% less funds holding

Funds holding: 102 → 101 (-1)

6% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 17

6% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 31

25% less capital invested

Capital invested by funds: $557M → $419M (-$138M)

56% less call options, than puts

Call options by funds: $131K | Put options by funds: $300K

Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
1.77%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
16
Increased
29
Reduced
31
Closed
17
Calls
$131K
Puts
$300K
Net Calls
-$169K
Net Calls Change
+$74K

Top Buyers

1
WP
Woodline Partners
California
+$3.84M
2
HCM
Highline Capital Management
New York
+$2.25M
3
Millennium Management
Millennium Management
New York
+$1.78M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.51M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.42M

Top Sellers

1
State Street
State Street
Massachusetts
-$13.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.1M
3
EA
Emerald Advisers
Pennsylvania
-$4.24M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$3.84M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
EMFAT
101
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$3.84M -14,511 Closed
Point72 Asset Management
102
Point72 Asset Management
Connecticut
– -$2.48M -9,375 Closed
Walleye Capital
103
Walleye Capital
New York
– -$1.12K -4,240 Closed
Rafferty Asset Management
104
Rafferty Asset Management
New York
– -$936K -3,534 Closed
Victory Capital Management
105
Victory Capital Management
Texas
– -$888K -3,353 Closed
GPCM
106
Granite Point Capital Management
Massachusetts
– -$530K -2,000 Closed
PPA
107
Parametric Portfolio Associates
Washington
– -$499K -1,884 Closed
Susquehanna International Group
108
Susquehanna International Group
Pennsylvania
– -$372K -1,562 Closed
Ensign Peak Advisors
109
Ensign Peak Advisors
Utah
– -$340K -1,283 Closed
Walleye Trading
110
Walleye Trading
New York
– -$323K -1,220 Closed
BFM
111
Boothbay Fund Management
New York
– -$204K -769 Closed
XT
112
XTX Topco
Cayman Islands
– -$164K -621 Closed
HA
113
HC Advisors
Georgia
– -$144K -546 Closed
Nisa Investment Advisors
114
Nisa Investment Advisors
Missouri
– -$48 -180 Closed
TFA
115
Toth Financial Advisory
Virginia
– -$1K -5 Closed
TWA
116
TCI Wealth Advisors
Arizona
– -$1K -3 Closed
SOW
117
State of Wyoming
Wyoming
– -$238 -1 Closed
1 2 3 4
5

PASG Hedge Fund Activity: Q3 2021 in Review

101 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q3 2021, worth a combined $419M — down 25% from $557M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of PASG and 16 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 29 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $3.84M. The largest seller was State Street, cutting an estimated $13.7M.

  • 101 institutional investors held Passage Bio (PASG) as of Q3 2021, down from 102 in Q2 2021.
  • Funds reported $419M of Passage Bio stock for Q3 2021, down 25% quarter-over-quarter.
  • 16 funds opened new Passage Bio positions in Q3 2021 and 17 closed out, a net change of -1 holder.
  • The largest Passage Bio buyer in Q3 2021 was Woodline Partners, an estimated $3.84M added.
  • The largest Passage Bio seller in Q3 2021 was State Street, an estimated $13.7M sold.

Based on aggregated 13F filings for Q3 2021.